Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Would you offer RT to a patient who had a RP showing pT3b pN1 Gleason 9 prostate cancer with elevated post-op PSA?
Would it matter if their PET axumin was negative?
Answer from: Radiation Oncologist at Academic Institution
If Axumin PET is negative for metastatic sites (prostatic Bed or Pelvic Nodes are excluded) Or even totally negative, I would treat.
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
I would favor pet scan if meets threshold based on psa and plan treatment accordingly
Sign in or Register to read more
6190
6181
Related Questions
What duration androgen deprivation do you recommend with salvage pelvic radiotherapy for pelvic node relapse after prostatectomy?
What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?
How do you manage malignancies in patients with Birt-Hogg-Dubé syndrome (BHD)? Is there concern for increased radiosensitivity?
What adjuvant treatment would you recommend for high-risk papillary RCC with a positive IVC margin?
For patients with oligo-progressive prostate cancer fit for metastasis-directed therapy but ineligible for radiotherapy or surgery, how do you decide between the types of ablation available?
In what situations would a standard FDG PET/CT be useful in the evaluation of high risk prostate cancer?
How do you decide between internal versus external decompression of malignant obstruction of the ureter (MUO)?
For a patient with a rising PSA after prostatectomy with seminal vesicles being negative for disease at surgery, do you ever treat the prostate bed and seminal vesicle bed with different doses in an SIB plan?
Would you use fezolinetant for hot flashes for men on ADT?
How would you treat a patient with retroperitoneal lymphadenopathy that has been biopsy proven metastatic seminoma, who is not a candidate for orchiectomy, RPLND, or systemic therapy?